(Total Views: 159)
Posted On: 12/16/2021 8:30:54 AM
Post# of 26814
$PRQR News Article - ProQR Announces First Patients Dosed in Phase 2/3 Pivotal Trials of QR-421a for USH2A Mediated Retinitis Pigmentosa https://marketwirenews.com/news-releases/proq...43184.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼